Abstract
The intracellular environment hosts a large number of cancer- and other disease-relevant human proteins. Targeting these with internalized antibodies would allow therapeutic modulation of hitherto undruggable pathways, such as those mediated by protein–protein interactions. However, one of the major obstacles in intracellular targeting is the entrapment of biomacromolecules in the endosome. Here we report an approach to delivering antibodies and antibody fragments into the cytosol and nucleus of cells using trimeric cell-penetrating peptides (CPPs). Four trimers, based on linear and cyclic sequences of the archetypal CPP Tat, are significantly more potent than monomers and can be tuned to function by direct interaction with the plasma membrane or escape from vesicle-like bodies. These studies identify a tricyclic Tat construct that enables intracellular delivery of functional immunoglobulin-G antibodies and Fab fragments that bind intracellular targets in the cytosol and nuclei of live cells at effective concentrations as low as 1 μM.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All the data supporting the findings of this study are available within the Article, the Supplementary Information or the source data. The data are also available from the corresponding authors upon reasonable request. Source data are provided with this paper.
References
Carter, P. J. & Lazar, G. A. Next generation antibody drugs: pursuit of the ‘high-hanging fruit’. Nat. Rev. Drug Discov. 17, 197–223 (2018).
Verdine, G. L. & Walensky, L. D. The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. Clin. Cancer Res. 13, 7264–7270 (2007).
Stewart, M. P. et al. In vitro and ex vivo strategies for intracellular delivery. Nature 538, 183–192 (2016).
Samal, S. K. et al. Cationic polymers and their therapeutic potential. Chem. Soc. Rev. 41, 7147–7194 (2012).
Brooks, H., Lebleu, B. & Vivès, E. Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Del. Rev. 57, 559–577 (2005).
Peraro, L. & Kritzer, J. A. Emerging methods and design principles for cell-penetrant peptides. Angew. Chem. Int. Ed. 57, 11868–11881 (2018).
Pei, D. & Buyanova, M. Overcoming endosomal entrapment in drug delivery. Bioconjug. Chem. 30, 273–283 (2019).
Fu, A., Tang, R., Hardie, J., Farkas, M. E. & Rotello, V. M. Promises and pitfalls of intracellular delivery of proteins. Bioconjug. Chem. 25, 1602–1608 (2014).
Fawell, S. et al. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl Acad. Sci. USA 91, 664–668 (1994).
Cornelissen, B. et al. Imaging DNA damage in vivo using γH2AX-targeted immunoconjugates. Cancer Res. 71, 4539–4549 (2011).
Singh, K., Ejaz, W., Dutta, K. & Thayumanavan, S. Antibody delivery for intracellular targets: emergent therapeutic potential. Bioconjug. Chem 30, 1028–1041 (2019).
Brock, R. The uptake of arginine-rich cell-penetrating peptides: putting the puzzle together. Bioconj. Chem. 25, 863–868 (2014).
Madani, F., Lindberg, S., Langel, U., Futaki, S. & Gräslund, A. Mechanisms of cellular uptake of cell-penetrating peptides. J. Biophys. 2011, 414729 (2011).
Dougherty, P. G., Sahni, A. & Pei, D. Understanding cell penetration of cyclic peptides. Chem. Rev. 119, 10241–10287 (2019).
Milletti, F. Cell-penetrating peptides: classes, origin and current landscape. Drug Discov. Today 17, 850–860 (2012).
Nischan, N. et al. Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability. Angew. Chem. Int. Ed. 54, 1950–1953 (2015).
Herce, H. D. et al. Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells. Nat. Chem. 9, 762–771 (2017).
Schneider, A. F. L., Kithil, M., Cardoso, M. C., Lehmann, M. & Hackenberger, C. P. R. Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives. Nat. Chem. 13, 530–539 (2021).
Akishiba, M. et al. Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide. Nat. Chem. 9, 751–761 (2017).
Ovacik, M. & Lin, K. Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development. Clin. Transl. Sci. 11, 540–552 (2018).
Kauffman, W. B., Fuselier, T., He, J. & Wimley, W. C. Mechanism matters: a taxonomy of cell penetrating peptides. Trends Biochem. Sci. 40, 749–764 (2015).
Herce, H. D. & Garcia, A. E. Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes. Proc. Natl Acad. Sci. USA 104, 20805–20810 (2007).
Lawrence, M. S., Phillips, K. J. & Liu, D. R. Supercharging proteins can impart unusual resilience. J. Am. Chem. Soc. 129, 10110–10112 (2007).
Cronican, J. J. et al. Potent delivery of functional proteins into mammalian cells in vitro and in vivo using a supercharged protein. ACS Chem. Biol. 5, 747–752 (2010).
Freire, J. M., Almeida Dias, S., Flores, L., Veiga, A. S. & Castanho, M. A. R. B. Mining viral proteins for antimicrobial and cell-penetrating drug delivery peptides. Bioinformatics 31, 2252–2256 (2015).
Tung, C.-H., Mueller, S. & Weissleder, R. Novel branching membrane translocational peptide as gene delivery vector. Biorg. Med. Chem. 10, 3609–3614 (2002).
Angeles-Boza, A. M., Erazo-Oliveras, A., Lee, Y.-J. & Pellois, J.-P. Generation of endosomolytic reagents by branching of cell-penetrating peptides: tools for the delivery of bioactive compounds to live cells in cis or trans. Bioconjug. Chem. 21, 2164–2167 (2010).
Fu, J., Yu, C., Li, L. & Yao, S. Q. Intracellular delivery of functional proteins and native drugs by cell-penetrating poly(disulfide)s. J. Am. Chem. Soc. 137, 12153–12160 (2015).
Erazo-Oliveras, A. et al. Protein delivery into live cells by incubation with an endosomolytic agent. Nat. Methods 11, 861–867 (2014).
Erazo-Oliveras, A. et al. The late endosome and its lipid BMP act as gateways for efficient cytosolic access of the delivery agent dfTAT and its macromolecular cargos. Cell Chem. Biol. 23, 598–607 (2016).
Najjar, K. et al. Unlocking endosomal entrapment with supercharged arginine-rich peptides. Bioconj. Chem. 28, 2932–2941 (2017).
Kez, C., Lin, H., Peter, D. W. & Arwyn, T. J. Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles. Curr. Pharm. Des. 19, 2878–2894 (2013).
Jonkman, J., Brown, C. M., Wright, G. D., Anderson, K. I. & North, A. J. Tutorial: guidance for quantitative confocal microscopy. Nat. Protoc. 15, 1585–1611 (2020).
Herbert, A. GDSC colocalisation plugins http://www.sussex.ac.uk/gdsc/intranet/microscopy/UserSupport/AnalysisProtocol/imagej/colocalisation (2013).
Costes, S. V. et al. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86, 3993–4003 (2004).
Ramirez, O., García, A., Rojas, R., Couve, A. & Härtel, S. Confined displacement algorithm determines true and random colocalization in fluorescence microscopy. J. Microsc. 239, 173–183 (2010).
Söderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995–1000 (2006).
Rouet, R. et al. Receptor-mediated delivery of CRISPR-Cas9 endonuclease for cell-type-specific gene editing. J. Am. Chem. Soc. 140, 6596–6603 (2018).
Qian, Z. et al. Discovery and mechanism of highly efficient cyclic cell-penetrating peptides. Biochemistry 55, 2601–2612 (2016).
Liu, H., Gaza-Bulseco, G., Faldu, D., Chumsae, C. & Sun, J. Heterogeneity of monoclonal antibodies. J. Pharm. Sci. 97, 2426–2447 (2008).
Delavoie, F., Soldan, V., Rinaldi, D., Dauxois, J. Y. & Gleizes, P. E. The path of pre-ribosomes through the nuclear pore complex revealed by electron tomography. Nat. Commun. 10, 497 (2019).
Paci, G., Zheng, T., Caria, J., Zilman, A. & Lemke, E. A. Molecular determinants of large cargo transport into the nucleus. eLife 9, e55963 (2020).
Avrameas, A., Ternynck, T., Nato, F., Buttin, G. & Avrameas, S. Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc. Natl Acad. Sci. USA 95, 5601–5606 (1998).
Gordon, R. E., Nemeth, J. F., Singh, S., Lingham, R. B. & Grewal, I. S. Harnessing SLE autoantibodies for intracellular delivery of biologic therapeutics. Trends Biotechnol. 39, 298–310 (2021).
Bernardes, N. E. & Chook, Y. M. Nuclear import of histones. Biochem. Soc. Trans. 48, 2753–2767 (2020).
Placek, B. J., Harrison, L. N., Villers, B. M. & Gloss, L. M. The H2A.Z/H2B dimer is unstable compared to the dimer containing the major H2A isoform. Protein Sci. 14, 514–522 (2005).
Acknowledgements
We thank R. S. Wilson and C. Lang at the Department of Physiology, Anatomy and Genetics, Oxford University, for assistance with microscopy and L. Ittner and M. Gill for helpful discussions. We acknowledge funding support from Cancer Research UK (CRUK, C5255/A15935), a CRUK grant (C5255/A18085) through the CRUK Oxford Centre, the Medical Research Council (MC_PC_12004) and the Engineering and Physical Sciences Research Council (EPSRC) Oxford Centre for Drug Delivery Devices (EP/L024012/1). This work has also received support from the Wellcome Trust (grant no. 106169).
Author information
Authors and Affiliations
Contributions
O.T. designed, conceived and synthesized the Tat trimers, designed, conceived and acquired microscopy studies, performed data analysis and wrote the manuscript. F.C.-T. acquired and analysed microscopy data and performed the PLA assay. S.A. synthesized the IgG and Fab conjugates. R.C. carried out mass spectrometry of the Tat trimers. K.A.V. contributed to conception and design, data analysis and acquired funding and supervised the study. All authors reviewed and revised the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Chemistry thanks Wouter Verdurmen and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Membrane porosity following treatment with Tat-trimer.
(a, b) Addition of 40 μM propidium iodide (PI) 20 min after addition of 1 μM trimer; image at 30 min after start of experiment. Cells treated with tri-Tat A (a) co-stain with PI; cells treated with tri-cTat B (b) are PI negative. (c) Average fluorescence intensity of PI per cell, 45 min after the start of the experiment (n = 25). Cells treated with tri-Tat A show significantly higher PI uptake, indicative of pore formation. (d) Cells treated with tri-Tat A (solid line) or tri-cTat B (dotted line) for 60 min and metabolic activity as an indicator of cell viability assessed using MTT assay after 1 h, 2 h, 4 h, 3 days (n = 3 biologically independent experiments). Data presented as mean ± standard deviation. Scale bar: 20 μm.
Supplementary information
Supplementary Information
Supporting Information.
Source data
Source Data Fig. 1
Statistical source data for the main figures and Extended Data figures.
Source Data Fig. 2
Statistical source data for the main figures and Extended Data figures.
Source Data Fig. 3
Statistical source data for the main figures and Extended Data figures.
Source Data Fig. 4
Statistical source data for the main figures and Extended Data figures.
Source Data Fig. 6
Statistical Source Data for main Figures and Extended Data Figures
Source Data Extended Data Fig. 1
Statistical source data for the main figures and Extended Data figures.
Rights and permissions
About this article
Cite this article
Tietz, O., Cortezon-Tamarit, F., Chalk, R. et al. Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells. Nat. Chem. 14, 284–293 (2022). https://doi.org/10.1038/s41557-021-00866-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41557-021-00866-0
This article is cited by
-
Dynamically crosslinked nanocapsules for the efficient and serum-resistant cytosolic protein delivery
Nano Research (2024)
-
Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide
Journal of Nanobiotechnology (2022)
-
Peptides as molecular Trojan horses
Nature Chemistry (2022)
-
A glutamine-based single α-helix scaffold to target globular proteins
Nature Communications (2022)
-
First direct evidence for direct cell-membrane penetrations of polycationic homopoly(amino acid)s produced by bacteria
Communications Biology (2022)